Penumbra, Inc. (PEN): Price and Financial Metrics
PEN Price/Volume Stats
| Current price | $322.37 | 52-week high | $324.38 |
| Prev. close | $321.83 | 52-week low | $114.86 |
| Day low | $319.10 | Volume | 146,600 |
| Day high | $322.78 | Avg. volume | 341,322 |
| 50-day MA | $295.57 | Dividend yield | N/A |
| 200-day MA | $234.81 | Market Cap | 12.33B |
PEN Stock Price Chart Interactive Chart >
PEN POWR Grades
- PEN scores best on the Growth dimension, with a Growth rank ahead of 98.58% of US stocks.
- PEN's strongest trending metric is Value; it's been moving down over the last 179 days.
- PEN's current lowest rank is in the Value metric (where it is better than 14.86% of US stocks).
PEN Stock Summary
- With a price/earnings ratio of 1,815.38, PENUMBRA INC P/E ratio is greater than that of about 99.66% of stocks in our set with positive earnings.
- PEN's price/sales ratio is 13.3; that's higher than the P/S ratio of 92.02% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, PENUMBRA INC is reporting a growth rate of -166.99%; that's higher than merely 9.66% of US stocks.
- If you're looking for stocks that are quantitatively similar to PENUMBRA INC, a group of peers worth examining would be PETS, TDW, CINF, HGTY, and AMPS.
- Visit PEN's SEC page to see the company's official filings. To visit the company's web site, go to www.penumbrainc.com.
PEN Valuation Summary
- PEN's price/earnings ratio is 1804.5; this is 7387.55% higher than that of the median Healthcare stock.
- PEN's EV/EBIT ratio has moved up 2243.3 over the prior 93 months.
Below are key valuation metrics over time for PEN.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| PEN | 2023-05-23 | 13.2 | 11.4 | 1804.5 | 672.3 |
| PEN | 2023-05-22 | 13.8 | 11.9 | 1880.8 | 700.4 |
| PEN | 2023-05-19 | 13.7 | 11.9 | 1874.6 | 698.1 |
| PEN | 2023-05-18 | 13.6 | 11.8 | 1859.8 | 692.7 |
| PEN | 2023-05-17 | 13.6 | 11.7 | 1852.0 | 689.8 |
| PEN | 2023-05-16 | 13.7 | 11.8 | 1863.8 | 694.2 |
PEN Growth Metrics
- The 4 year revenue growth rate now stands at 99.67%.
- Its 4 year price growth rate is now at 120.95%.
- Its year over year cash and equivalents growth rate is now at 22.52%.
The table below shows PEN's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-12-31 | 847.133 | -55.661 | -2.002 |
| 2022-09-30 | 829.928 | -66.268 | -30.512 |
| 2022-06-30 | 806.367 | -16.909 | -19.391 |
| 2022-03-31 | 782.281 | 19.356 | -6.473 |
| 2021-12-31 | 747.59 | 9.502 | 5.284 |
| 2021-09-30 | 710.477 | 16.689 | 33.565 |
PEN's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- PEN has a Quality Grade of C, ranking ahead of 49.95% of graded US stocks.
- PEN's asset turnover comes in at 0.794 -- ranking 38th of 186 Medical Equipment stocks.
- IVC, NTUS, and MLSS are the stocks whose asset turnover ratios are most correlated with PEN.
The table below shows PEN's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.794 | 0.618 | 0.009 |
| 2021-03-31 | 0.728 | 0.610 | -0.030 |
| 2020-12-31 | 0.728 | 0.603 | -0.054 |
| 2020-09-30 | 0.738 | 0.635 | -0.038 |
| 2020-06-30 | 0.774 | 0.658 | 0.017 |
| 2020-03-31 | 0.880 | 0.676 | 0.079 |
PEN Price Target
For more insight on analysts targets of PEN, see our PEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $319.80 | Average Broker Recommendation | 1.31 (Strong Buy) |
Penumbra, Inc. (PEN) Company Bio
Penumbra Inc. is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. The company was founded in 2004 and is based in Alameda, CA.
Latest PEN News From Around the Web
Below are the latest news stories about PENUMBRA INC that investors may wish to consider to help them evaluate PEN as an investment opportunity.
7 High-Flying Stocks Destined to Crash Back to EarthWhat goes up must come down (even for outstanding enterprises), which clouds these overvalued stocks due for correction. |
Top Stocks for June 2023Southwestern Energy, Mirati Therapeutics, and First Solar are top US stocks Russell 3000 in June 2023 for value, growth, and momentum, respectively. |
Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated AspirationPenumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced the U.S. Food and Drug Administration (FDA) clearance and launch of Lightning Bolt™ 7, the most advanced and powerful arterial thrombectomy system on the market. Lightning Bolt 7 introduces a new method for removing blood clots, modulated aspiration, which pairs Penumbra's Lightning Intelligent Aspiration technology with an advanced microprocessor algorithm. When used together, Lightning Bolt 7 is |
What You Can Learn From Penumbra, Inc.'s (NYSE:PEN) P/SWith a price-to-sales (or "P/S") ratio of 13.3x Penumbra, Inc. ( NYSE:PEN ) may be sending very bearish signals at the... |
Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock ConferencePenumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at William Blair's 43rd Annual Growth Stock Conference on Wednesday, June 7, 2023. |
PEN Price Returns
| 1-mo | 3.76% |
| 3-mo | 29.11% |
| 6-mo | 49.11% |
| 1-year | 127.26% |
| 3-year | 80.05% |
| 5-year | 95.02% |
| YTD | 44.91% |
| 2022 | -22.57% |
| 2021 | 64.18% |
| 2020 | 6.53% |
| 2019 | 34.43% |
| 2018 | 29.86% |
Continue Researching PEN
Here are a few links from around the web to help you further your research on Penumbra Inc's stock as an investment opportunity:Penumbra Inc (PEN) Stock Price | Nasdaq
Penumbra Inc (PEN) Stock Quote, History and News - Yahoo Finance
Penumbra Inc (PEN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...